Calloway Nathaniel bought LFCR
January 9, 2024 · Form 4 insider transaction
Calloway Nathaniel bought 5,906 shares of Lifecore Biomedical, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,906
Price
N/A
Total value
N/A
InsiderCalloway Nathaniel
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 9, 2024
Filing dateJanuary 10, 2024
Shares owned after24,088
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.